• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Analysis of the mechanism of membranous proteolysis and the immunoregulation for Sjogren's syndrome

Research Project

Project/Area Number 12307040
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section一般
Research Field 病態科学系歯学(含放射線系歯学)
Research InstitutionThe University of Tokushima

Principal Investigator

HAYASHI Yoshio  The University of Tokushima, School of Dentistry, Department of Pathology, Professor, 歯学部, 教授 (00127854)

Project Period (FY) 2000 – 2003
KeywordsSjogren's syndrome / Apoptosis / Caspase / Autoantigen / α-fodrin / Fas Ligand / AICD / Estrogen-deficiency
Research Abstract

Primary Sjogren's syndrome is an autoimmune disorder characterized by lymphocytic infiltrates and destruction of the salivary and lacrimal glands, and systemic production of autoantibodies to the ribonucleoprotein (RNP) particles SS-A/Ro and SS-B/La. The purpose of this research is to elucidate the mechanisms on the development of primary Sjogren's syndrome. Although several candidate autoantigens including α-fodrin have been reported in Sjogren's syndrome, the pathogenic roles of the autoantisens in initiation and progression of SS are still unclear. It is possible that individual T cells activated by an appropriate self antigen can proliferate and form a restricted clone. Recent evidences suggest that the apoptotic pathway plays a central role in tolerazing T cells to tissue-specific self antigen, and may drive the autoimmune phenomenon. Cleavage of certain autoantigens during apoptosis may reveal immunocryptic epitopes that could potentially induce autoimmune response. The studies reviewed imply that Fas-mediated cytotoxicity and caspase-mediated α-fodrin proteolysis are involved in the progression of tissue destruction in Sjogren's syndrome. Fas ligand (FasL), and its receptor Fas are essential in the homeostasis of the peripheral immune system. It can be considered that a defect in activation-induced cell death (AICD) of effector T cells may result in the development of autoimmune exocrinopathy in Sjogren's syndrome. Although the mechanisms by which estrogen deficiency influences autoimmune lesions remain unclear, it is possible that antiestrogenic actions might be a potent factor in the formation of pathogenic autoantigens

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Hayashi Y, Arakaki R, Ishimaru N.: "Apoptosis, and estrogen deficiency in primary Sjogren's syndrome."Cur.Opin.Rheumatol. (in press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoneda T, et al.: "Estrogen deficiency accelerates murine autoimmune arthritis associated with RANKL-mediated osteoclastogenesis."Endocrinol.. (in press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ishimaru N, et al.: "Development of autoimmune exocrinopathy resembling Sjogren's syndrome in estrogen-deficient mice of healthy background."Am.J.Pathol.. 163. 1481-1490 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Katunuma N, et al.: "Insights into the roles of cathepsins in antigen processing and presentation revealed by specific inhibitors."Biol.Chem.. 348. 883-890 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hayashi Y, Arakaki R, Ishimaru N.: "The role of caspase cascade on the development of primary Sjogren's syndrome."J.Med.Invest.. 50. 32-38 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Arakaki R, et al.: "Development of autoimmune exocrinopathy resembling Sjogren's syndrome in adoptively transferred mice with autoreactive CD4^+ T cell."Arthritis Rheum.. 48. 3603-3609 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ogawa K, et al.: "Anti-α-fodrin autoantibodies in Moyamoya disease."Stroke. 34. 244-246 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hayashi Y Arakaki R, Ishimaru N.: "Apoptosis, and estrogen deficiency in primary Sjogren's syndrome"Cur.Opin.Rheumatol. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoneda T, et al.: "estrogen deficiency accelerates murine autoimmune arthritis associated with RANKL-mediated osteoclastogenesis"Endocrinol.. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishimaru N, et al.: "Development of autoimmune exocrinopathy resembling Sjogren's syndrome in,, estrogen-deficient mice of healthy thy ground"Am.J.Pathol.. 163. 1481-1490 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Katunuma N, et al.: "Insights into the roles of cathepsins in antigen processing and presentation revealed by s specific inhibitors"Biol Chem.. 384. 883-890 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hayashi Y, Arakaki, R., Ishimaru N.: "The role of caspase cascade on the development of primary Sjogren's syndrome"J.Med.Invest.. 50. 32-38 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Arakaki R, et al.: "Development of autoimmune exocrinopathy 2-esembling Sjogren's syndrome in adoptively transferred mice with autoreactive CD4^+ T cell"Arthritis Rheum. 48. 3603-3609 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ogawa K, et al.: "Anti-α-fodrin autoantibodies in Moyamoya disease"Stroke. 34. 244-246 (2003)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi